BIOMAT Database Logo BIOMAT Database Logo

[Hydergin in hypertension therapy]. 1951

E F VON HUEBER, and K WOHLRAB

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D010120 Oxytocics Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D004876 Ergot Alkaloids Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists. Clavine Alkaloids,Alkaloids, Clavine,Alkaloids, Ergot

Related Publications

E F VON HUEBER, and K WOHLRAB
[Hydergin therapy of hypertension].
December 1950, Wiener klinische Wochenschrift,
E F VON HUEBER, and K WOHLRAB
[Hydergin therapy of hypertension].
July 1954, Arztliche Wochenschrift,
E F VON HUEBER, and K WOHLRAB
[Therapy of hypertension with hydergin].
July 1952, Medizinische Monatsschrift,
E F VON HUEBER, and K WOHLRAB
[Therapy of arterial hypertension by hydergin].
February 1952, Lyon medical,
E F VON HUEBER, and K WOHLRAB
[Hydergin therapy of hypertension; past and future].
October 1951, Helvetica medica acta,
E F VON HUEBER, and K WOHLRAB
[Treatment of hypertension with hydergin].
September 1951, Deutsche medizinische Wochenschrift (1946),
E F VON HUEBER, and K WOHLRAB
[Intermittent claudication; hydergin therapy].
January 1954, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E F VON HUEBER, and K WOHLRAB
[Hypertension in old age. Treatment with Hydergin].
October 1983, ZFA. Zeitschrift fur Allgemeinmedizin,
E F VON HUEBER, and K WOHLRAB
[Hydergin therapy in late pregnancy toxemia].
October 1951, Magyar noorvosok lapja,
E F VON HUEBER, and K WOHLRAB
[Effect of hydergin on the fundus in hypertension].
November 1954, Therapie der Gegenwart,
Copied contents to your clipboard!